Press release
Biologics CDMO Market is projected to reach a revised size of US$ 23690 million by 2028, growing at a CAGR of 10.9% | Valuates Reports
Biologics CDMO MarketDue to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Biologics Contract Development and Manufacturing Organization(CDMO) estimated at US$ 12710 million in the year 2022, is projected to reach a revised size of US$ 23690 million by 2028, growing at a CAGR of 10.9% during the forecast period 2022-2028.
Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-1K12829/Global_Biologics_CDMO_Market_Research_Report_2022
North American market for Biologics CDMO is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Biologics CDMO is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Biologics CDMO include Lonza Group AG, Samsung Biologics, AbbVie, WuXi Biologics, Toyobo, AGC, Thermo Fisher Scientific, ICON Plc and Boehringer Ingelheim, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Biologics CDMO in Cell Therapy is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Biological Agent, which accounted for % of the global market of Biologics CDMO in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
This report aims to provide a comprehensive presentation of the global market for Biologics CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics CDMO.
The Biologics CDMO market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Biologics CDMO market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics CDMO manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
By Company
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
• Lonza Group AG
• Samsung Biologics
• AbbVie
• WuXi Biologics
• Toyobo
• AGC
• Thermo Fisher Scientific
• ICON Plc
• Boehringer Ingelheim
• Fujifilm Diosynth Biotechnologies
By Type
• Biological Agent
• Biosimilar Drug
By Application
• Cell Therapy
• Drug Development
• Others
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-1K12829/global-biologics-cdmo
Similar Reports:
1. https://reports.valuates.com/market-reports/QYRE-Auto-36L1348/global-biopharmaceutical-cmo-cro
2. https://reports.valuates.com/market-reports/QYRE-Auto-8X11656/global-cosmetic-cdmo-and-cmo
3. https://reports.valuates.com/market-reports/QYRE-Auto-39T13723/global-pharmaceutical-cdmo
https://reports.valuates.com/sitemap/html/reports/518
https://reports.valuates.com/sitemap/html/reports/519
https://reports.valuates.com/sitemap/html/reports/520
Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biologics CDMO Market is projected to reach a revised size of US$ 23690 million by 2028, growing at a CAGR of 10.9% | Valuates Reports here
News-ID: 2992250 • Views: …
More Releases from Valuates Reports
2-Oxazolidinone Market Revenue, Insights, Overview, Outlook, Analysis | Valuates …
2-Oxazolidinone Market Size
The global market for 2-Oxazolidinone was valued at US$ 732 million in the year 2024 and is projected to reach a revised size of US$ 916 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-1I12558/Global_2_Oxazolidinone_Market?utm_source=Openpr&utm_medium=Referral
This report aims to provide a comprehensive presentation of the global market for 2-Oxazolidinone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess…
Strontium-88 Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Re …
Strontium-88 Market Size
The global market for Strontium-88 was valued at US$ 89 million in the year 2024 and is projected to reach a revised size of US$ 126 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Download Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-34T9158/Global_Strontium_Market?utm_source=Openpr&utm_medium=Referral
This report aims to provide a comprehensive presentation of the global market for Strontium-88, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess…
Cobalt Sulfate Heptahydrate Market Revenue, Insights, Overview, Outlook, Analysi …
Cobalt Sulfate Heptahydrate Market Size
The global market for Cobalt Sulfate Heptahydrate was valued at US$ 449 million in the year 2024 and is projected to reach a revised size of US$ 729 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-19T19438/Global_Cobalt_Sulfate_Heptahydrate_Market?utm_source=Openpr&utm_medium=Referral
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments…
Ultrasonic Fabric Cutting and Sealing Machine Market Revenue, Insights, Overview …
Ultrasonic Fabric Cutting and Sealing Machine Market Size
The global market for Ultrasonic Fabric Cutting and Sealing Machine was valued at US$ 1200 million in the year 2024 and is projected to reach a revised size of US$ 2091 million by 2031, growing at a CAGR of 8.2% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-12M18905/Global_Ultrasonic_Fabric_Cutting_and_Sealing_Machine_Market?utm_source=Openpr&utm_medium=Referral
This report aims to provide a comprehensive presentation of the global market for Ultrasonic Fabric Cutting and…
More Releases for Biologics
Advanced Biologics Manufacturing Solutions Market Future Business Opportunities …
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417
Focused on…
Biologics Fill Finish Manufacturing Market 2024-2031: Global Industry Size, Shar …
According to a new report published by CoherentMI The Biologics Fill Finish Manufacturing Market is estimated to be valued at USD 5.41 Billion in 2024 and is expected to reach USD 9.04 Billion by 2031, growing at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
Most recent Report, named "Biologics Fill Finish Manufacturing Market" Patterns, Offer, Size, Development, Opportunity and Forecast 2024-2031, by CoherentMI offers a…
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031
Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
Biologics Contract Manufacturing Market to Witness Huge Growth by 2031 | Wuxi Bi …
The Biologics Contract Manufacturing Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.
Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/biologics-contract-manufacturing-market
What is the…
Spine Biologics Market Report 2024 - Spine Biologics Market Trends And Share
"The Business Research Company recently released a comprehensive report on the Global Spine Biologics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Biologics Contract Manufacturing Market - Strategic biologics manufacturing part …
Newark, New Castle, USA: The "Biologics Contract Manufacturing Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Biologics Contract Manufacturing Market: https://www.growthplusreports.com/report/biologics-contract-manufacturing-market/8606
This latest report researches the industry structure,…